Cargando…
COVID-19 vaccines and kidney disease
Patients with kidney diseases should be prioritized for COVID-19 vaccination and the available data suggest that replication-defective viral-vectored vaccines and mRNA vaccines are safe to use. As vaccine responses are likely to be lower in patients with kidney diseases than in the general populatio...
Autores principales: | Windpessl, Martin, Bruchfeld, Annette, Anders, Hans-Joachim, Kramer, Holly, Waldman, Meryl, Renia, Laurent, Ng, Lisa F. P., Xing, Zhou, Kronbichler, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869766/ https://www.ncbi.nlm.nih.gov/pubmed/33558753 http://dx.doi.org/10.1038/s41581-021-00406-6 |
Ejemplares similares
-
COVID-19: implications for immunosuppression in kidney disease and transplantation
por: Kronbichler, Andreas, et al.
Publicado: (2020) -
Anti-GBM-Nephritis
por: Windpessl, Martin, et al.
Publicado: (2023) -
Timing of COVID-19 Vaccine in the Setting of Anti-CD20 Therapy: A Primer for Nephrologists
por: Kant, Sam, et al.
Publicado: (2021) -
COVID-19 vaccination in kidney transplant recipients
por: Caillard, Sophie, et al.
Publicado: (2021) -
COVID-19 vaccination in patients with immunity-mediated kidney disease
por: Prendecki, Maria, et al.
Publicado: (2021)